CB2 Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
CB2 Therapeutics General Information
Description
Provider of endocannabinoid system (ECS) with multi-omics and multi-targeted therapeutic options for the management of chronic inflammatory conditions. The company's therapeutics focuses on developing compounds for chronic inflammatory conditions with high unmet needs or that are poorly served with existing therapies.
Contact Information
Corporate Office
- Ottawa, Ontario
- Canada
Corporate Office
- Ottawa, Ontario
- Canada
CB2 Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CB2 Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CB2 Therapeutics FAQs
-
Where is CB2 Therapeutics headquartered?
CB2 Therapeutics is headquartered in Ottawa, Canada.
-
What industry is CB2 Therapeutics in?
CB2 Therapeutics’s primary industry is Drug Discovery.
-
Is CB2 Therapeutics a private or public company?
CB2 Therapeutics is a Private company.
-
What is CB2 Therapeutics’s current revenue?
The current revenue for CB2 Therapeutics is .
-
Who are CB2 Therapeutics’s investors?
Onegevity, Tetra Bio-Pharma, and Thorne Research have invested in CB2 Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process